株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の生物検知(Bio-Detection)による国家安全保障および防衛技術市場予測:2011〜2016年

U.S. Bio-Detection Homeland Security & Defense Technology & Market Forecast 2011-2016

発行 Homeland Security Research Corp. 商品コード 136443
出版日 ページ情報 英文 210 Pages; 118 Tables & Figures
納期: 即日から翌営業日
価格
こちらの商品の販売は終了いたしました。
Back to Top
米国の生物検知(Bio-Detection)による国家安全保障および防衛技術市場予測:2011〜2016年 U.S. Bio-Detection Homeland Security & Defense Technology & Market Forecast 2011-2016
出版日: 2010年11月01日 ページ情報: 英文 210 Pages; 118 Tables & Figures

当商品の販売は、2016年07月01日を持ちまして終了しました。

概要

当レポートでは、生物検知装置市場および技術動向に焦点を当て、現在および次世代技術の概要、将来のビジネス機会、2016年までの市場予測などについてまとめ、概略下記の構成でお届けいたします。

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 生物検知市場:促進因子

第4章 生物検知市場:阻害因子

第5章 生物検知業界競合分析

第6章 生物検知業界SWOT分析

第7章 生物検知市場動向

第8章 バイオテロリズムからの防衛

第9章 オバマ政権のバイオテロ戦略

  • バイオサーベイランスネットワーク
  • 資金
  • 戦略

第10章 技術概要

  • 技術的課題
  • 検出プロセス

第11章 技術的課題

第12章 技術レビューと見通し:2011〜2016年

  • コア技術比較
  • コレクター/コンセントレーターコア技術
  • サイクロンコレクター
  • 粒子サイズの衝撃体
  • バーチャル衝撃体 他

第13章 アプリケーション別概要

第14章 米国の生物検知システム市場の今後の見通し:2011〜2016年

第15章 サービスおよびアップグレードビジネス:2011〜2016年

第16章 生物検知のビジネスチャンス:2011〜2016年

第17章 人的要因

第18章 ベンダー

第19章 生物検知装置の価格

第20章 付録A:バイオテロの脅威

第21章 付録B:法的事項

図表

目次

Despite nine years of intensive RDT&E and bio-terror mitigation programs implementation, at a cost of more than $50 billion, virtually all significant targets are as vulnerable to biological terror today as they were in September 2001.

In the words of President Obama: “we know that the successful deployment of a biological weapon - whether it is sprayed into our cities or spread through our food supply - could kill tens of thousands of Americans and deal a crushing blow to our economy. ”Meeting this challenge will require, among other things, shortening the bio-attack alarm response time, premium detection sensitivity and selectivity at a reasonable cost of ownership.

We forecast that over the next five years, led by 3rd generation technologies the US bio-detection market (including systems sale, service, consumables and upgrades) will grow from $1.3 billion in 2010 to $2.6 billion by 2016.

With more than 210 pages, 41 tables and 77 figures, granulated into more than 90 sub-markets this report represents a comprehensive bio-detection technologies and markets.

The report delves into:

  • Market by systems sales, upgrade and service markets
  • Market by first, second and third generation technologies
  • Market by indoor, outdoor, hand-held and mobile labs segment
  • Market by end user (e.g. 1st responders)
  • Systems prices
  • Installed base by product and user categories
  • Leading US bio-security projects
  • 27 vendors and their products
  • Current and pipeline technologies (e.g. advanced collectors-concentrators, reagent-less triggers, DNA-based diagnostics, antigen/anti-body methods, signal analysis algorithms)
  • Competitive analysis (e.g. barriers to entry, barriers to substitution, competitive rivalry)
  • Business opportunities (e.g. emerging threats, human and animal sentinel surveillance, reagent-less detection assays, IC3 compatibility)
  • SWOT analysis
  • Market drivers and inhibitors
  • And more...

Table of Contents

1. Executive Summary

  • 1.1 Main Findings
  • 1.2 Main Conclusions
  • 1.3 Bio-Detection Market Forecast - 2011-2016
    • 1.3.1 Overview
    • 1.3.2 Systems and Service & Upgrade Markets - 2011-2016
    • 1.3.3 Systems & Service Market by Modality - 2011-2016
    • 1.3.4 Systems & Service Market by Technology Generation - 2011-2016
  • 1.4 Bio-Detection - Next Generation Business Opportunities
  • 1.5 Technologies Outlook

2. Introduction

  • 2.1 Scope
  • 2.2 Methodology
    • 2.2.1 Research Methods
    • 2.2.2 Report Structure
    • 2.2.3 Assumptions
  • 2.3 Who is This Report For?

3. Bio-Detection Market - Drivers

4. Bio-Detection Market - Inhibitors

5. Bio-Detection Industry Competitive Analysis

6. Bio-Detection Industry SWOT Analysis

7. Bio-detection Market Dynamics

8. Defending Against Bioterrorism

  • 8.1 Definition of Bioterrorism
  • 8.2 The Threat of Bioterrorism
  • 8.3 How Real Is The Bioterrorism Threat?
  • 8.4 Bio-Defense Programs
    • 8.4.1 Strategy
    • 8.4.2 Project BioWatch
    • 8.4.3 Project BioSense
    • 8.4.4 Project BioShield
  • 8.5 Bio-Detection - The Industry

9. The Obama Administration Bio Terror Mitigation Strategy

  • 9.1 Biosurveillance Network
  • 9.2 Bio-Defense Funding
    • 9.2.1 Overview
    • 9.2.2 DHHS Bio-Defense Missions and Funding
    • 9.2.3 DHS Bio-Defense Missions and Funding
    • 9.2.4 DOD Bio-Defense Missions and Funding
    • 9.2.5 DOA Bio-Defense Missions and Funding
    • 9.2.6 EPA Bio-Defense Missions and Funding
  • 9.3 The Obama Administration Bio-Defense Strategy

10. Bio-Detection - Technologies Overview

  • 10.1 Bio-Detection Technology Challenges
    • 10.1.1 Sampling the Environment
  • 10.2 The Bio-Detection Process
    • 10.2.1 Bio-Detectors in a Multitude of Ambient Settings
    • 10.2.2 Bio-Detection Triggering
    • 10.2.3 Collection of Particles
    • 10.2.4 Bio-Particle Detectors
    • 10.2.5 Bio-Agent Identification

11. Major Bio-Detection Technological Challenges

  • 11.1 Challenge 1 - Detection of Small Particle Concentration
  • 11.2 Challenge 2 - Eliminating Bio Background
  • 11.3 Challenge 3 - Expensive Reagents
  • 11.4 Challenge 4 - Expensive Equipment Maintenance
  • 11.5 Challenge 5 - Adapting Equipment to Changing Environments
  • 11.6 Challenge 6 - Dealing With Emerging Threats

12. Bio Detection Technologies Review & Outlook - 2011-2016

  • 12.1 Bio-Detection - Core Technologies Comparison
  • 12.2 Collector/Concentrator Core Technologies
  • 12.3 Cyclone Collectors
  • 12.4 Variable Particle-Size Impactor
  • 12.5 Virtual Impactors
  • 12.6 Impingers
  • 12.7 Reagentless Trigger Core Technologies
    • 12.7.1 Flow Cytometry
    • 12.7.2 Particle Sizing
    • 12.7.3 Gas Chromatography
    • 12.7.4 Trigger Technologies - Drivers
    • 12.7.5 Trigger Technologies - Inhibitors
  • 12.8 DNA Based Diagnostic Core Technologies
    • 12.8.1 Overview of DNA-Based Detection
    • 12.8.2 Polymerase Chain Reaction (PCR)
    • 12.8.3 DNA / RNA Microarrays
    • 12.8.4 DNA Technology Drivers
    • 12.8.5 DNA Technology Inhibitors
  • 12.9 Antibody-Antigen Diagnostic Core Technologies
    • 12.9.1 Overview of Antibody-Antigen Reaction
    • 12.9.2 Hand-Held Immuno-Chromatographic Assays (HHA)
    • 12.9.3 Magnetic Microbead-Base Assays
    • 12.9.4 Microfluidic Devices - “Lab on a Chip”
    • 12.9.5 Fluorescence Imaging
    • 12.9.6 Electrochemical-Luminescence (ECL)
    • 12.9.7 Antibody/Antigen Technology - Drivers
    • 12.9.8 Antibody/Antigen Technology - Inhibitors
  • 12.1 Signal Analysis Algorithms
    • 12.10.1 Clustering / Classifier Algorithms
    • 12.10.2 Image Analysis Algorithms
    • 12.10.3 Decision Algorithms
    • 12.10.4 Algorithm Drivers
    • 12.10.5 Algorithm Inhibitors
  • 12.11 Rapid Microbiological Technologies

13. Biological Detection - Overview by Application

  • 13.1.1 Application 1 - Emergency Responder Hand-Held Detectors
  • 13.1.2 Application 2 - Emergency Responder Mobile Labs
  • 13.1.3 Application 3 - Indoor Standoff Detectors
  • 13.1.4 Application 4 - Outdoor Standoff Detectors

14. U.S. Bio-Detection Systems Market Outlook - 2011-2016

  • 14.1 Methodology
  • 14.2 Bio-Detection Systems Sales - 2011-2016
    • 14.2.1 Bio-Detection Systems Revenue Sales by Generation Forecast - 2011-2016
    • 14.2.2 Bio-Detection Systems Sales by Modality - 2011-2016
  • 14.3 Bio-Detection Systems Quantity Sales - 2011-2016
    • 14.3.1 Bio-Detection Systems Quantity Sales by Generation - 2011-2016
    • 14.3.2 Bio-Detection Systems Quantity Sales by Modality - 2011-2016
  • 14.4 Outdoor Bio-Detection Systems Market - 2011-2016
    • 14.4.1 Outdoor Standoff Detection Systems Revenue Sales Outlook - 2011-2016
    • 14.4.2 Outdoor Standoff Detection Systems Quantity Sales Outlook - 2011-2016
  • 14.5 Indoor Bio-Detection Systems Market- 2011-2016
    • 14.5.1 Indoor Standoff Systems Detection Sales - 2011-2016
    • 14.5.2 Indoor Standoff Systems Unit Sales - 2011-2016
  • 14.6 First Responder Hand-Held Bio-Detection Systems Market - 2011-2016
    • 14.6.1 First Responder Hand-Held Systems Sales - 2011-2016
    • 14.6.2 First Responder Hand-Held Systems Quantity Sales - 2011-2016
  • 14.7 Mobile Bio-Detection Labs Market - 2011-2016
    • 14.7.1 First Responder Mobile Labs Sales - 2011-2016
    • 14.7.2 First Responder Mobile Labs Quantity Sales - 2011-2016

15. Service & Upgrade Business - 2011-2016

  • 15.1 Bio-Detection Service & Upgrade Business by Modality - 2011-2016
  • 15.2 Bio-Detection Service Business by Technology Generation - 2011-2016

16. Business Opportunities in Bio-Detection - 2011-2016

  • 16.1 Historical Perspective
    • 16.1.1 A Market Waiting for Transition
    • 16.1.2 The Current and Future HLS Bio-Defense Strategy for Detection
    • 16.1.3 Factors Affecting Biological Detectors Deployment and Technologies - 2011-2016
    • 16.1.4 Biological Detection Technology Timeline
  • 16.2 Next Generation HLS Bio-Detection Systems Business Opportunities
    • 16.2.1 Overview
    • 16.2.2 Business Opportunity 1 - Emerging Threats
    • 16.2.3 Business Opportunity 2 - Human Sentinel Surveillance System
    • 16.2.4 Business Opportunity 3 - Animal Sentinel Surveillance System
    • 16.2.5 Business Opportunity 4 - Biological IC3 - Biological Threat Assessment Intelligence Command, Control, and Communication Infrastructure
    • 16.2.6 Business Opportunity 5 - Reducing False Alarms - Lesser False Positives and False Negatives
    • 16.2.7 Business Opportunity 6 - Reducing Cost - Minimizing Use of Non-Reusable Reagents
  • 16.3 Outdoor Standoff Biological Detectors
    • 16.3.1 Business Opportunity 7 - Bioagent Autonomous Networked Detectors (BAND)
    • 16.3.2 Business Opportunity 8 - Rapid Automated Biological Identification System (RABIS)
    • 16.3.3 Business Opportunity 9 - First Responder Portable Hand-Held Detector
    • 16.3.4 Business Opportunity 10 - First Responder Mobile Biological Detection Station
    • 16.3.5 Business Opportunity 11 - Regional Automatic Detector - Outdoor Standoff Detectors
    • 16.3.6 Business Opportunity 12 - Networked Automatic Detector - Indoor Standoff Detectors
    • 16.3.7 Business Opportunity 13 - External Spread of Bioagent Detection
    • 16.3.8 Business Opportunity 14 - Internal Spread of Bioagent
  • 16.4 Other Bio-Detection Technologies - Business Opportunities
    • 16.4.1 Business Opportunity 15 - “Lab on a Chip” - Miniature Detection Devices
    • 16.4.2 Business Opportunity 16 - Reagentless Specific Detection Assays
    • 16.4.3 Business Opportunity 17 - Laser Induced Breakdown Spectroscopy (LIBS)
    • 16.4.4 Business Opportunity 18 - Raman Spectroscopy-based Reagentless Detection
  • 16.5 Future Technologies and Systems

17. Bio-Detection - Personnel Considerations

  • 17.1 Background - Personnel
  • 17.2 Personnel Training

18. Vendors

  • 18.1 20/20 GeneSystems Inc.
  • 18.2 Advnt Biotechnologies
  • 18.3 Agilent Technologies
  • 18.4 Alexeter Technologies
  • 18.5 ANP Technologies, Inc.
  • 18.6 BAS - Biological Alarm Systems Ltd. (Israel)
  • 18.7 BD Biosciences Immunocytometry Systems
  • 18.8 Bertin Technologies
  • 18.9 BioDefense Corporation
  • 18.1 BioDETECT AS
  • 18.11 BioSentinel Pharmaceuticals LLC
  • 18.12 3M Microbiology (Biotrace International, Ltd.)
  • 18.13 BioTraces, Inc.
  • 18.14 BioVeris Corporation
  • 18.15 Biral
  • 18.16 Cepheid
  • 18.17 Commonwealth Biotechnologies, Inc.
  • 18.18 Dycor Technologies Ltd.
  • 18.19 Environics Oy
  • 18.20 Evogen, Inc.
  • 18.21 General Dynamics Canada
  • 18.22 GenPrime, Inc.
  • 18.23 Groton Biosystems
  • 18.24 Haztech Systems, Inc.
  • 18.25 Idaho Technology, Inc.
  • 18.26 JMAR Technologies, Inc.
  • 18.27 New Horizons Diagnostics
  • 18.28 Proengin
  • 18.29 QTL Biodetection
  • 18.30 Research International
  • 18.31 Response Biomedical
  • 18.32 Roche Applied Science
  • 18.33 Smiths Detection
  • 18.34 Tetracore, Inc.

19. Prices of Bio-Detection Equipment

20. Appendix A: The Threat of Bioweapons

  • 20.1 Use of Bioweapons - Historical Perspective
  • 20.2 Biological Terror - Bacterial Agents
    • 20.2.1 Anthrax
    • 20.2.2 Cholera
    • 20.2.3 Plague
    • 20.2.4 Tularemia
  • 20.3 Biological Terror - Viral Agents
    • 20.3.1 Smallpox
    • 20.3.2 Hemorrhagic Fever Viruses
    • 20.3.3 Venezuelan Equine Encephalitis
  • 20.4 Biological Terror - Rickettsiae Agents
    • 20.4.1 Q Fever
    • 20.4.2 Typhus
  • 20.5 Biological Terror - Toxins
    • 20.5.1 Botulinum Toxin
    • 20.5.2 Ricin
    • 20.5.3 Saxitoxin
    • 20.5.4 Staphylococcal Enterotoxin B (SEB)

21. Appendix B: Legal Issues

  • 21.1 International / European Legislation / Agreements
    • 21.1.1 The Biological and Toxin Weapons Convention (BTWC) 1972
  • 21.2 U.S. Bioterrorism Legislation

List of Tables

  • Table 1 - US HLS & Defense Bio-Detection Systems and Service Market [$M] 2010 & 2016 - by Product Classification
  • Table 2 - U.S. HLS Bio-Detection Systems and Service Market Forecast [$ Million] - 2010-2016
  • Table 3 - U.S. HLS Bio-Detection Systems & Service (S&S) Market Forecast by Expenditure Share [%] - 2010-2016
  • Table 4 - U.S. HLS Bio-Detection Systems & Service Market by Portability [$ Million] - 2010-2016
  • Table 5 - U.S. HLS Bio-Detection Systems & Service Market by Modality Share [%] - 2010-2016
  • Table 6 - Bio-Detection Systems Sales by Generation [$ Million] - 2010-2016
  • Table 7 - Bio-Detection Systems Sales by Generation [%] - 2010-2016
  • Table 8 - Bio-Detection Service and Upgrade Business Forecast by Technology Generation [$ Million] - 2010-2016
  • Table 9 - Bio-Detection Service and Upgrade Business Forecast by Technology Generation Share [%] - 2008-2014
  • Table 10 - Evolution of Bio-detection Market Dynamics - 2010-2014
  • Table 11 - U.S. Federal HLS-HLD Bio-Defense Funding [$ Million], by Agency - FY2001-FY2011
  • Table 12 - Comparison of Attributes of Bio-Detection Technologies
  • Table 13 - Bio-Detection Systems Sales by Generation [$ Million] - 2010-2016
  • Table 14 - Bio-Detection Systems Sales by Generation Share [%] - 2010-2016
  • Table 15 - Bio-Detection Consolidated Sales by Modality [$M] - 2010-2016
  • Table 16 - Bio-Detection Systems Sales by Modality Share [%] - 2010-2016
  • Table 17 - Bio-Detection Systems Quantity Sales by Generation [Units] - 2010-2016
  • Table 18 - Bio-Detection Systems Quantity Sales by Generation Share [%] - 2010-2016
  • Table 19 - Bio-Detection Systems Quantity Sales by Modality [Units] - 2010-2016
  • Table 20 - Bio-Detection Systems Quantity Sales by Modality Share [%] - 2010-2016
  • Table 21 - Outdoor Standoff Detectors Systems Sales by Generation [$ Million] - 2010-2016
  • Table 22 - Outdoor Standoff Detectors Systems Sales by Generation Share [%] - 2010-2016
  • Table 23 - Outdoor Standoff Detectors Systems Sales [Units] - 2010-2016
  • Table 24 - Outdoor Standoff Detectors Systems Sales Share [%] - 2010-2016
  • Table 25 - Indoor Standoff Systems Sales by Generation [$M] - 2010-2016
  • Table 26 - Indoor Standoff Detectors Systems Sales by Generation Share [%] - 2010-2016
  • Table 27 - Indoor Standoff Systems Sales by Generation [Units] - 2010-2016
  • Table 28 - Indoor Standoff Detectors Systems Sales by Generation Share [%] - 2010-2016
  • Table 29 - First Responder Hand-Held Detection Systems Sales [$M] by Generation - 2010-2016
  • Table 30 - First Responder Hand-Held Detection Systems Sales by Generation Share [%] - 2010-2016
  • Table 31 - First Responder Hand-Held Systems Sales [Units] by Generation - 2010-2016
  • Table 32 - First Responder Hand-Held Systems Sales by Generation Share [%] - 2010-2016
  • Table 33 - First Responder Mobile Labs Sales by Generation [$M] - 2010-2016
  • Table 34 - First Responder Mobile Labs Sales by Generation Share [%] - 2010-2016
  • Table 35 - First Responder Mobile Labs Sales by Generation [Units] - 2010-2016
  • Table 36 - First Responder Mobile Labs Unit Sales by Generation Share [%] - 2010-2016
  • Table 37 - Bio-Detection Service & Upgrade Business by Modality [$M] - 2010-2016
  • Table 38 - Bio-Detection Service & Upgrade Business by Modality Share [%] - 2010-2016
  • Table 39 - Bio-Detection - Service Business by Technology Generation [$M] - 2010-2016
  • Table 40 - Bio-Detection Service Business Forecast by Technology Generation Share [%] - 2010-2016
  • Table 41 - Prices of Bio-Detection Equipment

List of Figures

  • Figure 1 - Cumulative Civilian Biodefense Funding by Agency, FY2001-FY2011 [$M]
  • Figure 2 - US HLS & Defense Bio-Detection Systems and Service Market [$M] 2010 & 2016 - by Product Classification
  • Figure 3 - U.S. HLS Bio-Detection Systems & Service Market [$ Million] - 2010-2016
  • Figure 4 - U.S. HLS Bio-Detection Systems & Service Market Share [%] - 2010, 2013 & 2016
  • Figure 5 - U.S. HLS Bio-Detection Systems & Service Market Forecast by Modality [$ Million] - 2010-2016
  • Figure 6 - U.S. HLS Bio-Detection Systems & Service Market Forecast by Modality Share [%] - 2010, 2013 & 2016
  • Figure 7 - Bio-Detection Systems Sales by Generation [$ Million] - 2010-2016
  • Figure 8 - Bio-Detection Service Business by Technology Generation [$ Million] - 2010-2016
  • Figure 9 - Types of Biological Detectors
  • Figure 10 - Bio-Detection Industry Competitive Analysis
  • Figure 11 - Bio-Detection Industry SWOT Analysis
  • Figure 12 - Bio-Detection Strategy - Three Pillars Diagram
  • Figure 13 - BioShield Timeline and Funding
  • Figure 14 - Bio-Detection Responsibilities across the US Federal Bio-surveillance Network
  • Figure 15 - U.S. Government HLS-HLD Bio-Defense Funding [$ Million] - FY2001-FY2011
  • Figure 16 - Cumulative 2001-2011 Bio-Defense Funding [$Million], by Agency
  • Figure 17 - Bio-Defense Funding Share [%], by Agency - 2001, 2006 & 2011
  • Figure 18 - Comparison in Weight of Pathogens Between BW Agents and CW Agents [mg]
  • Figure 19 - Typical Point Detection Automated Architecture (With a Combined Trigger/Cue)
  • Figure 20 - Airborne Bacterial Concentration Fluctuation in a Single Day
  • Figure 21 - Cross-Section of Cascade Impactor: PIXE International Corporation
  • Figure 22 - TSI' s Model 3317 System with Concentrator, GPS Receiver & Wireless Data Radio
  • Figure 23 - Biological Detection Technologies - 2010-2016
  • Figure 24 - Flow Cytometry
  • Figure 25 - Gas Chromatography
  • Figure 26 - Polymerase Chain Reaction
  • Figure 27 - RT- PCR
  • Figure 28 - Principles of Real-Time PCR
  • Figure 29 - DNA Microarrays - Principles of Operation
  • Figure 30 - Schematic for Antibody Protein
  • Figure 31 - Hand Held Detectors: Alexeter Guardian Reader System and Tetracore Test Strips
  • Figure 32 - Roche Applied Science - Light CyclerTM Model 1.2
  • Figure 33 - Bio-Detection Systems Sales by Generation [$M] - 2010-2016
  • Figure 34 - Bio-Detection Systems Sales by Generation Share [%] - 2010, 2013 & 2016
  • Figure 35 - Bio-Detection Systems Sales by Modality [$M] - 2010-2016
  • Figure 36 - Bio-Detection Systems Sales by Modality Share [%] - 2010, 2013 & 2016
  • Figure 37 - Bio-Detection Systems Quantity Sales by Generation [Units] - 2010-2016
  • Figure 38 - Bio-Detection Systems Quantity Sales by Generation Share [%] - 2010, 2013 & 2016
  • Figure 39 - Bio-Detection Systems Quantity Sales by Modality [Units] - 2010-2016
  • Figure 40 - Bio-Detection Systems Quantity Sales by Modality Share [%] - 2010, 2013 & 2016
  • Figure 41 - Outdoor Systems Standoff Detectors Sales by Generation [$M] - 2010-2016
  • Figure 42 - Outdoor Standoff Detectors Systems Sales by Generation Share [%] - 2010, 2013 & 2016
  • Figure 43 - Outdoor Standoff Detectors Systems Sales [Thousand of Units] - 2010-2016
  • Figure 44 - Outdoor Standoff Detectors Systems - Sales Share [%] - 2010, 2013 & 2016
  • Figure 45 - Indoor Standoff Detectors Systems Sales by Generation [$M] - 2010-2016
  • Figure 46 - Indoor Standoff Detectors Systems Sales by Generation Share [%] - 2010, 2013 & 2016
  • Figure 47 - Indoor Standoff Systems Sales by Generation [Units] - 2010-2016
  • Figure 48 - Indoor Standoff Systems Sales by Generation Share [%] - 2010, 2013 & 2016
  • Figure 49 - First Responder Hand-Held Detection Systems Sales [$M] by Generation - 2010-2016
  • Figure 50 - First Responder Hand-Held Detection Systems Sales by Generation Share [%] - 2010, 2013 & 2016
  • Figure 51 - First Responder Hand-Held Detection Systems Sales by Generation [Units] - 2010-2016
  • Figure 52 - First Responder Hand-Held Detection Systems Sales by Generation Share [%] - 2010, 2013 & 2016
  • Figure 53 - First Responder Mobile Labs Sales by Generation [$M] - 2010-2016
  • Figure 54 - First Responder Mobile Labs Sales by Generation Share [%] - 2010, 2013 & 2016
  • Figure 55 - First Responder Mobile Labs Sales by Generation [Units] - 2010-2016
  • Figure 56 - First Responder Mobile Labs Unit Sales by Generation Share [%] - 2010, 2013 & 2016
  • Figure 57 - Bio-Detection Service & Upgrade Business Forecast by Modality [$M] - 2010-2016
  • Figure 58 - Bio-Detection Service & Upgrade Business Forecast by Modality Share [%] - 2010, 2013 & 2016
  • Figure 59 - Bio-Detection Service & Upgrade Business by Technology Generation [$M] - 2010-2016
  • Figure 60 - Bio-Detection Service & Upgrade Business by Technology Generation [%] - 2010, 2013 & 2016
  • Figure 61 - Factors Affecting Biological Detection Deployment and Technologies - 2010-2016
  • Figure 62 - Bio-Detection Timeline
  • Figure 63 - Civilians in China During the SARS Epidemic
  • Figure 64 - A Typical Microfluidic Device
  • Figure 65 - BAS101 Scheme
  • Figure 66 - The Spraying of Anthrax from Aum Shinrikyo' s Headquarters June 1993
  • Figure 67 - Anthrax Spores and Disease
  • Figure 68 - Cholera Bacteria
  • Figure 69 - Pneumonic Plague - The Disease
  • Figure 70 - Tularemia - The Disease
  • Figure 71 - Smallpox Virus And Disease
  • Figure 72 - Ebola Virus - Electron Microscopy Image
  • Figure 73 - VEE - Venezuelan Equine Encephalitis Virus in the Olfactory Mucosa of a Mouse
  • Figure 74 - Q Fever
  • Figure 75 - Typhus Microbe - Electron Microscopy Image
  • Figure 76 - Castor Plant And Structure For The Ricin Toxin
  • Figure 77 - The Dinoflagellate Alexandrium Tamarense And Structure of Saxitoxin
Back to Top